BAX · NYSE
Baxter International (BAX) Stock Price & Fundamentals
Baxter International (BAX) closed at $577.83 on Oct 9, 2026, down 0.12% from the previous close of $578.50.
Share price, past year
1Y +11.44%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $577.83 |
| Sep 30, 2026 | $575.72 |
| Aug 31, 2026 | $606.67 |
| Jul 31, 2026 | $613.57 |
| Jun 30, 2026 | $589.29 |
| May 29, 2026 | $577.84 |
| Apr 30, 2026 | $563.81 |
| Mar 31, 2026 | $564.17 |
| Feb 27, 2026 | $534.82 |
| Jan 30, 2026 | $506.05 |
| Dec 31, 2025 | $507.83 |
| Nov 28, 2025 | $515.02 |
| Oct 31, 2025 | $516.07 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $11.47B
- Net income (TTM)
- −$1.06B
- Shares outstanding
- —
- Dividend yield
- 0.03%
- 52-week range
- $500.61 – $628.79
Financials
Baxter International reported revenue of $11.24B for fiscal 2025, up 5.72% from fiscal 2024.
Baxter International reported a net loss of $957.00M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $11.24B | +5.7% | −$957.00M | −8.5% | −$1.87 | — |
| FY2024ended Dec 31, 2024 | $10.64B | +2.7% | −$649.00M | −6.1% | −$1.27 | — |
| FY2023ended Dec 31, 2023 | $10.36B | +3.0% | $2.66B | 25.6% | $5.23 | — |
| FY2022ended Dec 31, 2022 | $10.06B | −17.2% | −$2.43B | −24.2% | −$4.83 | — |
| FY2021ended Dec 31, 2021 | $12.15B | +4.1% | $1.28B | 10.6% | $2.53 | — |
| FY2020ended Dec 31, 2020 | $11.67B | +2.7% | $1.10B | 9.4% | $2.13 | — |
| FY2019ended Dec 31, 2019 | $11.36B | +2.4% | $1.00B | 8.8% | $1.93 | — |
| FY2018ended Dec 31, 2018 | $11.10B | +4.9% | $1.55B | 13.9% | $2.83 | — |
| FY2017ended Dec 31, 2017 | $10.58B | +4.1% | $602.00M | 5.7% | $1.08 | — |
| FY2016ended Dec 31, 2016 | $10.16B | — | $4.97B | 48.9% | $9.01 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.96B | $126.00M | $0.24 |
| Q1 FY2026ended Mar 31, 2026 | $2.70B | −$15.00M | −$0.03 |
| Q4 FY2025ended Dec 31, 2025 | $2.97B | −$1.13B | — |
| Q3 FY2025ended Sep 30, 2025 | $2.84B | −$46.00M | −$0.09 |
| Q2 FY2025ended Jun 30, 2025 | $2.81B | $91.00M | $0.18 |
| Q1 FY2025ended Mar 31, 2025 | $2.63B | $126.00M | $0.25 |
| Q4 FY2024ended Dec 31, 2024 | $2.75B | −$512.00M | −$1.00 |
| Q3 FY2024ended Sep 30, 2024 | $2.70B | $140.00M | $0.27 |
Company profile
- Name
- Baxter International Inc.
- Ticker
- BAX
- Exchange
- NYSE
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- One Baxter Parkway, Deerfield, IL 60015
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000010456
Recent SEC filings
- Aug 19, 2026
- Aug 18, 2026
- Aug 4, 2026
- Aug 4, 2026
- Jul 30, 2026
- Jul 30, 2026
- Jul 14, 2026
- May 8, 2026
Frequently asked questions
What is Baxter International's stock price?
Baxter International (BAX) closed at $577.83 on Oct 9, 2026, down 0.12% from the previous close of $578.50.
How much revenue does Baxter International make?
Baxter International reported revenue of $11.24B for fiscal 2025, up 5.72% from fiscal 2024.
Does Baxter International pay a dividend?
Yes. Baxter International declared $0.20 per share in dividends over the last four quarters, a yield of 0.03%.
Sources and methodology
Fundamentals come from Baxter International Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures